Clinical Study Results (SURMOUNT & SURPASS) Tirzepatide has been evaluated in large phase 3 clinical studies in humans: Weight reduction: In the SURMOUNT studies, participants achieved up to 20.9% mean body-weight loss at the highest dose
What makes GHK-Cu unique is that it acts as a cellular signaling peptide, something like a messenger that tells your skin what to do
Factors such as age, environmental pollutants, and daily stress can gradually lower the amount your body produces
SELENOP appears to be especially critical for selenium homeostasis in the brain and testes where apolipoprotein E receptor 2 (apoER2) facilitates the uptake of SELENOP
Vitamin B12 injections may be recommended for men experiencing low energy, fatigue, or symptoms associated with vitamin B12 deficiency
He also runs Tirzepatide 0.5mg three times per week but that sits outside the core stack